ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding ImageneBio, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 33 | 41 | +8 |
| Shares | 4.75M | 4.77M | +21.0K (+0.4%) |
| Value | $38.3M | $32.9M | −$5.43M (−14.2%) |
New holders (14)
Institutions that held ImageneBio, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cable Car Capital LLC | 643,933 | $4.44M | 0.28% |
| Monashee Investment Management LLC | 91,621 | $632.2K | 0.36% |
| DRW Securities, LLC | 43,768 | $302.0K | 0.02% |
| HSBC Holdings PLC | 34,228 | $233.1K | 0.00% |
| Nano Cap New Millennium Growth Fund L P | 26,500 | $182.8K | 0.16% |
| Shay Capital LLC | 23,216 | $160.2K | 0.03% |
| Jane Street Group, LLC | 14,896 | $102.8K | 0.00% |
| Prelude Capital Management, LLC | 13,495 | $93.1K | 0.01% |
| T3 Companies, LLC | 13,200 | $91.1K | 0.12% |
| Millennium Management LLC | 11,454 | $79.0K | 0.00% |
| Goldman Sachs Group Inc | 10,950 | $75.6K | 0.00% |
| Royal Bank of Canada | 1,000 | $7.00K | 0.00% |
| Fortitude Family Office, LLC | 400 | $2.76K | 0.00% |
| Avion Wealth | 57 | $0 | 0.00% |
Sold out (6)
Institutions that held ImageneBio, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Deep Track Capital, LP | 878,516 | $7.16M |
| Atlas Venture Life Science Advisors, LLC | 377,814 | $3.08M |
| Bridgeway Capital Management, LLC | 12,774 | $104.1K |
| Tower Research Capital LLC (TRC) | 877 | $7.15K |
| Federated Hermes, Inc. | 204 | $1.66K |
| FMR LLC | 67 | $546 |